BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220929T103000
DTEND;TZID=America/New_York:20220929T163000
DTSTAMP:20260403T163750
CREATED:20220816T161557Z
LAST-MODIFIED:20220816T161557Z
UID:3021-1664447400-1664469000@www.ctnnortheastnode.org
SUMMARY:“Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment" Virtual Workshop
DESCRIPTION:REGISTER HERE! \nDescription: \nObservational research and digital health studies have made significant progress in recent years\, including target trial emulations using real-world data (RWD) and translational testing of digital health tools in real-world settings. This workshop aims to introduce these trending approaches; assess their strengths\, limitations\, and potential; discuss feasible research questions; identify study priorities\, and explore actionable strategies to address barriers and challenges for advancing substance use disorder (SUD) research. \nOnce registered you will receive the Zoom information including an option to download a calendar invitation. \nIf you have any questions about the meeting logistics\, please contact CTNSupport@leedmci.com. If you have any questions about this event\, please contact Dr. Xiaoming Wang at xiaoming.wang@nih.gov. \nIndividuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event\, should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event. \n 
URL:https://www.ctnnortheastnode.org/event/target-trial-emulation-in-observational-research-and-translational-testing-of-advanced-digital-health-tools-for-sud-prevention-and-treatment-virtual-workshop/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220929T103000
DTEND;TZID=America/New_York:20220929T163000
DTSTAMP:20260403T163750
CREATED:20220908T010803Z
LAST-MODIFIED:20220908T010920Z
UID:3040-1664447400-1664469000@www.ctnnortheastnode.org
SUMMARY:Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment
DESCRIPTION:REGISTER HERE! \nDescription: \nThis workshop aims to introduce these trending approaches; assess their strengths\, limitations\, and potential; discuss feasible research questions; identify study priorities\, and explore actionable strategies to address barriers and challenges for advancing substance use disorder (SUD) research. \nMeeting Chair: Lisa Marsch\, Ph.D. – Dartmouth College \nThe workshop consists of three subthemes with the following speakers:\nLearning Real-World Evidence of SUD from Nationwide Data Sources\nChristopher Jones\, Pharm.D.\, Dr.PH.\, M.P.H. – Centers for Disease Control and Prevention\nBeth Han\, M.D.\, Ph.D.\, M.P.H. – National Institute on Drug Abuse\, National Institutes of Health\nJulie Donohue\, Ph.D. – University of Pittsburgh \nTarget Trial Emulation in Observational Research\nSara Lodi\, Ph.D. – Boston University\nRolf Groenwold\, Ph.D. – Leiden University\, Netherlands\nJoshua Wallach\, Ph.D. M.S. – Yale University\nMarc LaRochelle\, M.D.\, M.P.H. – Boston University \nTranslational Testing of Clinical- and Community-Based Digital Health Systems\nBrandon Marshall\, Ph.D. – Brown University\nRebecca Rossom\, M.D.\, M.S. – HealthPartners\nJenny Lo-Ciganic\, Ph.D.\, M.S.Pharm. – University of Florida\nWalid Gellad\, M.D.\, M.P.H. – University of Pittsburgh\nMajid Afshar\, M.D.\, MSCR – University of Wisconsin-Madison \nOnce registered\, you will receive the Zoom information\, including an option to download a calendar invitation. If you have any questions about the meeting logistics\, please contact CTNSupport@leedmci.com. If you have any questions about this event\, please contact Dr. Xiaoming Wang at xiaoming.wang@nih.gov. \nIndividuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.
URL:https://www.ctnnortheastnode.org/event/target-trial-emulation-in-observational-research-and-translational-testing-of-advanced-digital-health-tools-for-sud-prevention-and-treatment/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221006
DTEND;VALUE=DATE:20221008
DTSTAMP:20260403T163750
CREATED:20220810T180210Z
LAST-MODIFIED:20220810T180210Z
UID:3008-1665014400-1665187199@www.ctnnortheastnode.org
SUMMARY:Annual VCBH Conference: Contingency Management for Increasing Abstinence  from Substance Use and Promoting Health in Vulnerable Populations
DESCRIPTION:After holding our past two conferences fully remote\, we are excited to offer a hybrid conference for the first time. We will be returning to our location at the Hilton Burlington Lake Champlain for those that enjoy the experience of connecting in person and love coming to Vermont in the fall. A virtual option is available for those unable to attend in person. \nProof of vaccination is required at registration on site. We are following Vermont State Health Department guidance for our conference and ask that you consider wearing a mask. If any guidance changes prior to our conference\, we will make all necessary adjustments. \nWe are at a pivotal time for contingency management (CM) in the US. This fall\, California will become the first state in the country to launch a pilot program of CM with a Medicaid benefit. We will have speakers specifically discussing the California program and key implementation issues\, legal implications\, and the application and advancement of contingency management in various health areas including substance use disorder\, tobacco cessation\, and cardiac rehabilitation. Speakers include: \n\nKen Silverman\, PhD: Keynote\nBarbara Andraka-Christou\, PhD\, JD\nSara Becker\, PhD\nH. Westley Clark\, MD\, MPH\, JD\nThomas E. Freese\, PhD\nMichael G. McDonnell\, PhD\n\nAttend In Person – Options for in-person attendance include: \n\nattend both Oct 6th and 7th\nattend Oct 6th only\nattend Oct 7th only\n\nAttend Virtually \nAttend our entire conference virtually from the comfort of your home or office. Or\, maybe you can only attend one day in person and need to attend one day virtually. \nRegister Now
URL:https://www.ctnnortheastnode.org/event/annual-vcbh-conference-contingency-management-for-increasing-abstinence-from-substance-use-and-promoting-health-in-vulnerable-populations/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221013T143000
DTEND;TZID=America/New_York:20221013T153000
DTSTAMP:20260403T163750
CREATED:20220817T181305Z
LAST-MODIFIED:20220817T181305Z
UID:3032-1665671400-1665675000@www.ctnnortheastnode.org
SUMMARY:What has Brain Imaging Taught us about Addiction?
DESCRIPTION:Edythe London\, PhD will be joining us to discuss how the imaging of brain structure\, chemistry and function is possible using noninvasive techniques that have been applied to the study of addiction. She will cover how it is possible to identify regional and circuit-level abnormalities that maintain drug misuse and promote a return to drug use after the initiation of abstinence. \nThis event is FREE and OPEN to the public. To register\, click the button below or use the following link: http://ow.ly/wZam50Kh11p. \n\n\n\nCLICK HERE TO REGISTER
URL:https://www.ctnnortheastnode.org/event/what-has-brain-imaging-taught-us-about-addiction/
CATEGORIES:Other Related
ORGANIZER;CN="Rural Drug Addiction Research Center":MAILTO:rdar@unl.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221019T123000
DTEND;TZID=America/New_York:20221019T133000
DTSTAMP:20260403T163750
CREATED:20221012T122957Z
LAST-MODIFIED:20221012T122957Z
UID:3050-1666182600-1666186200@www.ctnnortheastnode.org
SUMMARY:The Neurobiology of Addiction
DESCRIPTION:Presenter: Steven Straubing\, MD \nCost: No fee \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \n  \nRegister now!
URL:https://www.ctnnortheastnode.org/event/the-neurobiology-of-addiction/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221024T170000
DTEND;TZID=America/New_York:20221024T190000
DTSTAMP:20260403T163750
CREATED:20221017T162524Z
LAST-MODIFIED:20221017T162524Z
UID:3054-1666630800-1666638000@www.ctnnortheastnode.org
SUMMARY:Overdose Prevention and Harm Reduction: The Fundamentals of Addiction Medicine ECHO Session 1
DESCRIPTION:Register Now\n\n\n\nPresenters: J. Deanna Wilson\, MD\, MPH; Abby Letcher\, MD\, FASAM; Angela Colistra\, PhD\, LPC\, CAADC\, CCS; and Shanna Diaz\, DO \nSeries: The Fundamentals of Addiction Medicine ECHO (FAME) series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. Upon completion\, you will be able to utilize new skills and strategies to help you improve care for patients with addiction. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for On-Demand. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: This activity is designed for physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. This activity is accredited for physicians. \nCredit designations available: 2 AMA PRA Category 1 Credits™ \nWebinar Description: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nEducational Objectives: \n\nDevelop a community of mentors and colleagues to support professional development and build confidence in providing best practices in patient care for patients with addiction.\nAnalyze real patient cases to identify barriers to treatment and discuss solutions to overcome those barriers to ensure best evidence-based treatment options\, including pharmacological and non-pharmacological treatment\, for patients with addiction.\nDemonstrate professionalism in all interactions with patients and professional colleagues and demonstrate a commitment to the health and well-being of individuals and society through ethical practice\, profession-led regulation\, and high personal standards of behavior.\n\nContinuing Education information: \nACCME Accreditation Statement \nThe American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nAMA Credit Designation Statement \nThe American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \n  \n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/overdose-prevention-and-harm-reduction-the-fundamentals-of-addiction-medicine-echo-session-1/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221107T170000
DTEND;TZID=America/New_York:20221107T190000
DTSTAMP:20260403T163750
CREATED:20221031T115417Z
LAST-MODIFIED:20221031T115417Z
UID:3073-1667840400-1667847600@www.ctnnortheastnode.org
SUMMARY:Behavioral Interventions Integration of Skills into Addiction Medical Visits
DESCRIPTION:Register Now \nPresenters: Trina Fullard\, MA\, CCS\, LCAS; Abby Letcher\, MD\, FASAM; Angela Colistra\, PhD\, LPC\, CAADC\, CCS; and Shanna Diaz\, DO \nSeries: The Fundamentals of Addiction Medicine ECHO (FAME) series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. Upon completion\, you will be able to utilize new skills and strategies to help you improve care for patients with addiction. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for On-Demand. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: This activity is designed for physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. This activity is accredited for physicians. \nCredit designations available: 2 AMA PRA Category 1 Credits™ \nWebinar Description: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nEducational Objectives: \n\nDevelop a community of mentors and colleagues to support professional development and build confidence in providing best practices in patient care for patients with addiction.\nAnalyze real patient cases to identify barriers to treatment and discuss solutions to overcome those barriers to ensure best evidence-based treatment options\, including pharmacological and non-pharmacological treatment\, for patients with addiction.\nDemonstrate professionalism in all interactions with patients and professional colleagues and demonstrate a commitment to the health and well-being of individuals and society through ethical practice\, profession-led regulation\, and high personal standards of behavior.\n\nContinuing Education information: \nACCME Accreditation Statement \nThe American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nAMA Credit Designation Statement \nThe American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nRegister Now
URL:https://www.ctnnortheastnode.org/event/behavioral-interventions-integration-of-skills-into-addiction-medical-visits/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221130T120000
DTEND;TZID=America/New_York:20221130T130000
DTSTAMP:20260403T163750
CREATED:20221121T155703Z
LAST-MODIFIED:20221121T155703Z
UID:3097-1669809600-1669813200@www.ctnnortheastnode.org
SUMMARY:Applying Motivation-Phase Interventions to Treat Tobacco Use Among People with Opioid Use Disorder
DESCRIPTION:Register Now\n\nThis presentation will cover the importance of tobacco treatment for people with opioid use disorder and discuss research on providing treatment for smokers who are not motivated or not ready to quit. Lack of motivation or readiness to quit in the near future is a common barrier for tobacco use disorder and will be explored with a specific focus on those who live in rural communities. Register and attend to learn more!\nSpeaker:\nElias Klemperer\, PhD\, Associate Professor at the University of Vermont in the Departments of Psychiatry and Psychological Science and an investigator with the Vermont Center on Behavior and Health\n\n\n\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/applying-motivation-phase-interventions-to-treat-tobacco-use-among-people-with-opioid-use-disorder/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221201T160000
DTEND;TZID=America/New_York:20221201T170000
DTSTAMP:20260403T163750
CREATED:20221130T155207Z
LAST-MODIFIED:20221130T155207Z
UID:3103-1669910400-1669914000@www.ctnnortheastnode.org
SUMMARY:Suicide and Opioids: Intersections and Opportunities for Prevention
DESCRIPTION:Register Now\n\n\n\nPresenter: Ellyson Stout\, MS\, US Director of Community Suicide Prevention\, Education Development Center (EDC) \nSponsor: National Council for Mental Wellbeing–NCMW \n  \nTarget Audience: This activity is designed for mental health and addiction treatment professionals\, integrated care providers\, and medical staff. This activity is accredited for nurses\, physicians\, physician assistants\, social workers\, pharmacists\, interprofessional teams and other health professionals. \nAbout the webinar: Suicide is a leading cause of death in the United States\, with provisional estimates of over 47\,000 deaths in 2021. Nonetheless\, the evidence shows suicide can be prevented through comprehensive healthcare and community-based strategies\, as outlined in the Surgeon General’s Call to Action to Implement the National Strategy for Suicide Prevention. Substance misuse is a risk factor for suicide\, and people who use opioids are at increased risk for suicidal thoughts and behaviors. This webinar will provide an overview of risk and protective factors associated with suicidality and opioid use disorder (OUD)\, and will outline effective organizational and clinical prevention and intervention strategies for individuals experiencing OUD. \nEducational objectives: \n\nDescribe the broad context of suicide in the U.S. and what we know about suicide prevention.\nExamine the relationship between suicidality and opioid use disorder (OUD) from a public health standpoint.\nLeverage clinical intervention and prevention strategies and resources to address suicidality and OUD.\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/suicide-and-opioids-intersections-and-opportunities-for-prevention/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221206T130000
DTEND;TZID=America/New_York:20221206T140000
DTSTAMP:20260403T163750
CREATED:20221130T192244Z
LAST-MODIFIED:20221130T192244Z
UID:3106-1670331600-1670335200@www.ctnnortheastnode.org
SUMMARY:Utilizing Passively Collected Data in Daily Life to Enhance the Assessment and Treatment of Mental Health
DESCRIPTION:Register via Zoom \nDr. Nick Jacobson is a tenure-track assistant professor in the departments of Biomedical Data Science and Psychiatry within the Center for Technology and Behavioral Health in the Geisel School of Medicine at Dartmouth College. He directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory. Dr. Jacobson researches the use of technology to enhance both the assessment and treatment of anxiety and depression. His work has focused on (1) enhancing precision assessment of anxiety and depression using intensive longitudinal data\, (2) conducting multimethod assessment utilizing passive sensor data from smartphones and wearable devices\, and (3) providing scalable\, personalized technology-based treatments utilizing smartphones. He has a strong interest in creating personalized just-in-time adaptive interventions and the quantitative tools that make this work possible. To date\, Dr. Jacobson’s smartphone applications which assess and treat anxiety and depression have been downloaded and installed by more than 50\,000 people in over 100 countries. Dr. Jacobson is the principal investigator of an R01 Awarded from the National Institute of Mental Health studying the use of personalized deep learning models to predict rapid changes in major depressive disorder symptoms using passive sensor data from smartphones and wearable devices. \nRegister via Zoom
URL:https://www.ctnnortheastnode.org/event/utilizing-passively-collected-data-in-daily-life-to-enhance-the-assessment-and-treatment-of-mental-health/
CATEGORIES:Other Related
ORGANIZER;CN="Center for Behavioral Intervention Technologies":MAILTO:cbits@northwestern.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230111T120000
DTEND;TZID=America/New_York:20230111T130000
DTSTAMP:20260403T163750
CREATED:20221221T150930Z
LAST-MODIFIED:20221221T150930Z
UID:3123-1673438400-1673442000@www.ctnnortheastnode.org
SUMMARY:Recommendations for Culturally Recentering Reinforcement-Based Substance Use Disorder Interventions in Collaboration with Rural Tribal Communities
DESCRIPTION:This presentation will cover ways to culturally adapt and implement contingency management among rural American Indian and Alaska Native communities. This will be achieved by describing evidence around substance use disorder (SUD) in rural American Indian and Alaska Native communities\, discussing the importance of cultural adaptation for SUD treatment among members of rural Tribal communities\, and defining reinforcement-based SUD interventions. Register to learn more! \nSpeaker:\nKait Hirchak\, PhD\, MHPA (Eastern Shoshone)\, Assistant Professor at the Elson S. Floyd College of Medicine\, Washington State University \nRegister Now
URL:https://www.ctnnortheastnode.org/event/recommendations-for-culturally-recentering-reinforcement-based-substance-use-disorder-interventions-in-collaboration-with-rural-tribal-communities/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230118T120000
DTEND;TZID=America/New_York:20230118T130000
DTSTAMP:20260403T163750
CREATED:20230118T131550Z
LAST-MODIFIED:20230118T131550Z
UID:3191-1674043200-1674046800@www.ctnnortheastnode.org
SUMMARY:Tobacco Regulations Across the Continuum of Harm
DESCRIPTION:Tracy Smith\, PhD \nAssistant Professor of Psychiatry and Behavioral Services \nMedical University of South Carolina \n  \nThe VCBH Monthly Lecture Series was originally created as an in-person series designed as a way to interact and engage with top researchers in the intersectional fields we often work with at VCBH including behavior change\, addiction\, chronic disease\, and health disparities for people who are at increased risk. Following the COVID-19 pandemic\, the VCBH made remote viewing available for the lecture series. While we are now moving back to in-person presentations at the UVM Medical Center\, remote attendees can still view this presentation via Zoom. If you wish to attend remotely\, please register through the link below. \n  \n\n\n\nRemote Registration
URL:https://www.ctnnortheastnode.org/event/tobacco-regulations-across-the-continuum-of-harm/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230123T170000
DTEND;TZID=America/New_York:20230123T190000
DTSTAMP:20260403T163750
CREATED:20230116T171427Z
LAST-MODIFIED:20230116T171427Z
UID:3186-1674493200-1674500400@www.ctnnortheastnode.org
SUMMARY:Alcohol Use Disorder (FAME Session #3)
DESCRIPTION:Presenters: Abby Letcher\, MD\, FASAM; Angela Colistra\, PhD\, LPC\, CAADC\, CCS; Shanna Diaz\, DO \nSeries: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for on-demand viewing. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: This activity is designed for physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. This activity is accredited for physicians. \nCredit designations available: 2 AMA PRA Category 1 Credits™ \nEducational Objectives: Upon completion\, learners will be able to: \n\nDevelop a community of mentors and colleagues to support professional development and build confidence in providing best practices in patient care for patients with addiction.\nAnalyze real patient cases to identify barriers to treatment and discuss solutions to overcome those barriers to ensure best evidence-based treatment options\, including pharmacological and non-pharmacological treatment\, for patients with addiction.\nDemonstrate professionalism in all interactions with patients and professional colleagues and demonstrate a commitment to the health and well-being of individuals and society through ethical practice\, profession-led regulation\, and high personal standards of behavior.\n\nRegister Now \nQuestions about registering should be directed to: ASAM Education by email ateducation@asam.org
URL:https://www.ctnnortheastnode.org/event/alcohol-use-disorder-fame-session-3/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230124T130000
DTEND;TZID=America/New_York:20230124T140000
DTSTAMP:20260403T163750
CREATED:20230120T224539Z
LAST-MODIFIED:20230120T224539Z
UID:3194-1674565200-1674568800@www.ctnnortheastnode.org
SUMMARY:The Connection Between Mental Health and Opioid Use Disorder
DESCRIPTION:Presenter: Mark Duncan\, MD\, Assistant Professor\, University of Washington\, Director\, UW Psychiatry and Addictions Case Conference \nSponsor: American Psychiatric Association (APA) \nCost: No Fee \nTarget audience: Physicians\, nurse practitioners or other advanced practice nurses\, PAs\, social workers\, pharmacists\, and healthcare teams \nCredit Designations Available: AAPA Category 1 CME\, Social Work CE Credit\, Nursing Contact Hours\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: There is a high prevalence of mental health disorders among those with opioid use disorder. However\, many practitioners still find it difficult to distinguish between differential diagnoses that may have similar symptomatology\, especially in regards to mental health and substance misuse. This webinar will enable participants to summarize the prevalence of common co-morbid mental illness\, explain the relationships between concurrent mental health and opioid use disorder (OUD) and recognize risk factors associated with both mental health disorders and OUD. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nSummarize the prevalence of common co-morbid mental health (MH) disorders.\nExplain genetic and environmental relationship between concurrent MH disorders and Opioid Use Disorder (OUD).\nDescribe the impact that co-occurring MH and OUD can have on treatment of both.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/the-connection-between-mental-health-and-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230208T120000
DTEND;TZID=America/New_York:20230208T130000
DTSTAMP:20260403T163750
CREATED:20230202T151257Z
LAST-MODIFIED:20230202T151257Z
UID:3196-1675857600-1675861200@www.ctnnortheastnode.org
SUMMARY:Comparing Methods of Buprenorphine Treatment Initiation in Patients Using Fentanyl
DESCRIPTION:Presenter: Adam Bisaga\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis talk discusses substance use disorder treatment in a post-COVID world. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/comparing-methods-of-buprenorphine-treatment-initiation-in-patients-using-fentanyl/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230214T120000
DTEND;TZID=America/New_York:20230214T130000
DTSTAMP:20260403T163750
CREATED:20230210T164844Z
LAST-MODIFIED:20230210T164844Z
UID:3199-1676376000-1676379600@www.ctnnortheastnode.org
SUMMARY:Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation
DESCRIPTION:Presenter: Jennifer McNeely\, MD \nSponsor: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) \nCost: No Fee \nTarget audience: Physicians\, psychologists\, social workers\, physician assistants\, pharmacists\, interprofessional team\, residents/fellows\, medical students\, other mental health clinicians \nCredit Designations Available: AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Social Work CE Credit\, Nursing Contact Hours\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: Substance use drives poor health outcomes in the general population. SUD continues to lead to more death and disability than any other preventable condition\, with alcohol being the third leading cause of preventable death in the United States. Drug-related overdoses also continue to climb with > 108\,000 overdose deaths per year as well as the leading all-cause mortality under the age of 50. Primary care is generally not thought of as a place to access mental health care\, but it may be a critical tool in noticing substance use behaviors and proactively loop patients into needed care. This webinar aims to introduce screening tools that can be administered during primary care visits. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nApply the screening guidelines and current state of the evidence to your practice.\nReview and evaluate screening instruments introduced in the webinar.\nConsider screening implementation in general medical settings based on the needs of your current patients.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/screening-for-substance-use-in-primary-care-screening-tools-and-guidance-for-implementation/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230222T120000
DTEND;TZID=America/New_York:20230222T130000
DTSTAMP:20260403T163750
CREATED:20230209T142208Z
LAST-MODIFIED:20230209T142208Z
UID:3198-1677067200-1677070800@www.ctnnortheastnode.org
SUMMARY:Illicit Drug Supply: Fentanyl and Xylazine
DESCRIPTION:Presenter: Richard Dawson\, PhD\, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry \nThis presentation will explore current information about fentanyl and xylazine including: drug supply information\, pharmacology\, clinical effects\, medical impacts\, harm reduction and treatment information. Considerations for rural populations will be discussed. \nRegister now! \n 
URL:https://www.ctnnortheastnode.org/event/illicit-drug-supply-fentanyl-and-xylazine/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T120000
DTEND;TZID=America/New_York:20230307T130000
DTSTAMP:20260403T163750
CREATED:20230307T121503Z
LAST-MODIFIED:20230307T121503Z
UID:3207-1678190400-1678194000@www.ctnnortheastnode.org
SUMMARY:Substance Use Disorders in Late Life
DESCRIPTION:Register Now \n  \nPresenters: Roberto D. Sanchez\, DO and Ali Abbas Asghar-Ali\, MD \nTarget Audience: This activity is designed for Psychiatrists\, Physicians\, Physician Assistants\, Nurses/Nurse Practitioners\, Social Workers\, Psychologists\, Pharmacists\, other mental health clinicians working within addiction. This activity is accredited for Physicians\, Physician Assistants\, Social Workers\, Pharmacists\, and Healthcare teams. \nCredit Designations Available: AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Social Work CE Credit\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nWebinar Description: The number of older adults is projected to exceed 72.1 million people by 2030 and members of the baby boomer generation have the highest rates of early life substance use which increases likelihood of substance use in later life. With rates of SUDs growing in older individuals\, this population is experiencing mood and anxiety disorders\, sleep disorders\, cognitive impairments\, sleep disruption\, hepatic complications\, and greater physical disability as co-morbid symptoms of substance use and aging. This webinar aims to improve awareness of the occurrence and impact of SUD as well as teach geriatric SUD screening tools. Finally\, the webinar will offer recommendations for pharmacologic and psychosocial treatments for SUD in older adults. \nEducational Objectives: \n\nGain awareness of the occurrence and impact of substance use disorders (SUDs) in late-life.\nEmploy appropriate screening tools to identify SUD in late-life.\nIdentify how SUDs in late-life differ from SUDs in younger adults.\nAdapt pharmacologic treatments for older adults with SUD.\nImplement recommendations for psychosocial treatments for the treatment of SUD.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/substance-use-disorders-in-late-life/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230309T130000
DTEND;TZID=America/New_York:20230309T140000
DTSTAMP:20260403T163750
CREATED:20230306T215025Z
LAST-MODIFIED:20230306T215025Z
UID:3206-1678366800-1678370400@www.ctnnortheastnode.org
SUMMARY:How Adding a Clinical Pharmacist Improves Access to Addiction Care
DESCRIPTION:Register here \nPresenters: \nBen Miskle\, PharmD\, University of Iowa Hospitals and Clinics \nAlison Lynch\, MD\, MS\, University of Iowa Hospitals and Clinics \nSponsor: American Academy of Addiction Psychiatry (AAAP) \nCost: No Fee \nTarget audience: Physicians\, nurse practitioners or other advanced practice nurses\, PAs\, social workers\, and pharmacists \nCredit designations available: Pharmacy CE Credit\, AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Nursing Contact Hours \, Social Work CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: There is a shortage of psychiatrists to meet the mental health needs of patients in the United States\, and this shortage was exacerbated by the COVID-19 pandemic. The incidence of substance use disorders (SUD) increased significantly during the pandemic and there is an insufficient number of physicians trained to meet patient needs. This gap creates problems across the healthcare system for providers\, patients and caregivers. One solution to this problem is integrating other members of the healthcare team to expand access to mental health and substance use treatments. Clinical pharmacists have extensive knowledge on pharmacologic treatment of SUD and are often underutilized resources. This presentation will highlight a successful model of how healthcare professionals can work together to coordinate and optimize care of patients living with SUD. The role of the psychiatric pharmacist as a partner in SUD care in different treatment settings will be explored and discussed. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDescribe how health care professionals can successfully work together to coordinate and optimize care of patients with substance use disorders (SUD).\nExamine the role of the pharmacist as a member of the interprofessional SUD team and the impact on patient care outcomes.\nIdentify SUD treatment settings where pharmacists can be integrated and the enhanced services that can be provided.\n\nRegister here
URL:https://www.ctnnortheastnode.org/event/how-adding-a-clinical-pharmacist-improves-access-to-addiction-care/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230317T120000
DTEND;TZID=America/New_York:20230317T130000
DTSTAMP:20260403T163750
CREATED:20230310T124420Z
LAST-MODIFIED:20230310T124420Z
UID:3208-1679054400-1679058000@www.ctnnortheastnode.org
SUMMARY:Nurses’ Practices with People Experiencing Opioid Use Disorder
DESCRIPTION:Register Now \n  \nPresenter: Timothy J. Sowicz\, PhD\, RN \nCost: No Fee \nTarget audience: This activity is designed for for Nurses\, MAT Team Providers\, Addictions Specialists\, SUD Project Directors\, Managers\, and Facilitators. This activity is accredited for nurses. \nCredit Designations Available: Nursing CE \nWebinar description: The purpose of this presentation is to present the findings from a narrative literature review that was conducted to understand nurses’ practices with persons with opioid use disorder (OUD). Nurses are a sizable portion of the healthcare workforce; therefore\, understanding their unique\, disciplinary contributions for people with OUD is important. Twenty-one studies were included in the review and most were non-experimental and conducted in Europe and North America. Nurses’ practices were described with various levels of specificity but aligned well with the scopes of practice of the American Nurses Society and the International Nurses Society on Addictions. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDiscuss the methods used for conducting this synthesis research.\nAnalyze professional scope of practice standards for nurses’ work with people with opioid use disorder\nSummarize at least two findings from the review\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/nurses-practices-with-people-experiencing-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230321T140000
DTEND;TZID=America/New_York:20230321T150000
DTSTAMP:20260403T163750
CREATED:20230317T205952Z
LAST-MODIFIED:20230317T205952Z
UID:3212-1679407200-1679410800@www.ctnnortheastnode.org
SUMMARY:Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches
DESCRIPTION:Register Now \nPresenters: Jonathan Craig Allen\, MD\, FASAM\, and Marc Fishman\, MD \nSponsor: National Council for Mental Wellbeing–NCMW \nContinuing education information: AMA PRA Category 1 Credit™\, Nursing Contact Hours\, AAPA Category 1 CME credit\, SW CE credit\, Pharmacy CE credit and IPCE credit \nTarget Audience: This activity is designed for physicians\, nurses\, PAs\, pharmacists\, social workers\, peer recovery support specialists\, psychologists\, other behavioral health providers. This activity is accredited for physicians\, nurses\, PAs\, pharmacists\, social workers\, interprofessional teams and other health professionals. \nAbout the webinar: Research indicates a lack of training and programming specific to treating and managing co-occurring opioid and stimulant use disorders\, despite the increased risk of overdose bolstered by the ever-changing and adulterated drug supply. While MOUD is the gold standard of care for treating OUD\, there are no FDA-approved medications for treating stimulant use disorder\, though behavioral therapies like contingency management have been well studied. These challenges highlight the need to identify promising treatment strategies to ensure individuals with co-occurring opioid and stimulant use disorders are effectively engaged in care to prevent overdose. This session will equip BH providers and organizations in this space\, including Community Behavioral Health Clinics (CCBHCs)\, with the tools necessary to effectively engage and provide quality\, team-based care and services to individuals with co-occurring opioid and stimulant use disorders in order to improve health outcomes\, reduce overdose risk\, and support long-term recovery. \nEducational objectives: \n\nDescribe the broad context of co-occurring opioid and stimulant use and overdose risk in the U.S.\nReview evidence-based strategies for treating opioid use disorders and promising practices for stimulant use\nIdentify evidence-based and promising strategies for treating co-occurring opioid and stimulant use disorders\nReview psychiatric co-morbidities associated with opioid and stimulant use disorders\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/co-occurring-opioid-and-stimulant-use-disorders-treatment-and-management-approaches/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230329T120000
DTEND;TZID=America/New_York:20230329T130000
DTSTAMP:20260403T163750
CREATED:20230315T133137Z
LAST-MODIFIED:20230315T133137Z
UID:3210-1680091200-1680094800@www.ctnnortheastnode.org
SUMMARY:Three years of the COVID-19 Pandemic: What we've learned\, and how it can make us better at treating rural patients with SUD
DESCRIPTION:This presentation will explore lessons learned from the COVID-19 pandemic as they relate to rural populations with substance use disorder. Register and attend to learn more! \nSpeaker:\nSarah Jacobs\, MD\, MEd\, Oculofacial Reconstructive Surgeon with the University of Alabama at Birmingham and the Science Writer for UVM CORA \nRegister Now
URL:https://www.ctnnortheastnode.org/event/three-years-of-the-covid-19-pandemic-what-weve-learned-and-how-it-can-make-us-better-at-treating-rural-patients-with-sud/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230405T120000
DTEND;TZID=America/New_York:20230405T133000
DTSTAMP:20260403T163750
CREATED:20230329T190608Z
LAST-MODIFIED:20230329T190608Z
UID:3215-1680696000-1680701400@www.ctnnortheastnode.org
SUMMARY:Treatment Considerations in the Age of Fentanyl
DESCRIPTION:Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems\, treatment providers\, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. \nSpeakers: – Kathryn Cates-Wessel\, CEO\, American Academy of Addiction Psychiatry – John J. Mariani\, MD\, Associate Professor of Clinical Psychiatry Division on Substance Use Disorders\, Columbia University – Tisha Wiley\, PhD\, Branch Chief\, Associate Director for Justice Systems\, NIDA – Jessica Hulsey\, Executive Director\, Addiction Policy Forum. \nPresenters will discuss practical clinical practice-based guidance on treating opioid use disorder in the age of fentanyl\, the use of medications for opioid use disorder (MOUD) in the treatment of individuals using fentanyl\, and other considerations and challenges. This free webinar is sponsored by the Addiction Policy Forum\, the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA)\, the American Academy of Addiction Psychiatry (AAAP)\, and the Providers Clinical Support System (PCSS). \n This webinar is part of the JCOIN Speaker Series. Led by the National Institute on Drug Abuse (NIDA) and funded by the NIH HEAL Initiative®\, JCOIN is a groundbreaking initiative designed to advance scientific knowledge on effective policies\, practices\, and interventions to address the opioid crisis among justice-involved individuals\, by partnering researchers with justice agencies and community health programs. \nRSVP
URL:https://www.ctnnortheastnode.org/event/treatment-considerations-in-the-age-of-fentanyl/
CATEGORIES:Other Related
ORGANIZER;CN="Addiction Policy Forum":MAILTO:info@addictionpolicy.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230406T150000
DTEND;TZID=America/New_York:20230406T160000
DTSTAMP:20260403T163750
CREATED:20230403T224440Z
LAST-MODIFIED:20230403T224440Z
UID:3218-1680793200-1680796800@www.ctnnortheastnode.org
SUMMARY:Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain\, Opioid Misuse\, and Opioid Use Disorder
DESCRIPTION:Register Now \n  \nPresenter: Eric Garland\, PhD\, LCSW \nSponsoring organization: American Society for Pain Management Nursing (ASPMN) \nTarget audience: Clinical providers including Physicians\, PAs and NPs \nAbout the webinar: Half of all people with a substance use disorder (SUD) have chronic pain\, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a case in point\, where physical and emotional pain fuel opioid addiction and continue to drive countless deaths of despair to this day. Unfortunately\, there are few evidence-based therapies that can simultaneously treat this complex comorbidity. To meet this need\, Mindfulness-Oriented Recovery Enhancement (MORE) was generated through a decade-long treatment development process funded by the National Institutes of Health. Rooted in affective neuroscience\, MORE unites mindfulness training\, cognitive-behavioral therapy\, and principles from positive psychology into an integrative therapy designed to target addiction\, stress\, and pain. This session will detail the theory underlying MORE\, research data demonstrating MORE’s effectiveness\, and unique clinical skills integral to this novel treatment. MORE has been tested in 11 clinical trials funded by more than $40 million in federal research grants. In the largest trial of MORE (250 patients with opioid misuse/OUD)\, MORE decreased opioid misuse by 45% by 9-month follow-up\, more than doubling the effect of standard therapy. MORE also significantly decreased chronic pain\, distress\, depression\, and PTSD. In addition\, MORE has been shown to improve outcomes among people receiving medication assisted treatment. Neuroscience shows that MORE decreases the extent to which the brain is triggered by drug cues\, while increasing brain responses to natural\, healthy rewards. MORE is now being disseminated across the U.S. This dissemination effort is urgently needed\, in light of the opioid settlement monies that are now reaching the states to help alleviate the opioid crisis. \nEducational objectives: \n\nIdentify three cognitive\, affective\, and neurobiological mechanisms implicated in substance use disorders\, affective disorders\, and chronic pain.\nExplain three therapeutic techniques to reduce craving\, regulate addictive behavior\, decrease negative emotions\, and/or manage chronic pain.\nDescribe the clinical outcomes of MORE for chronic pain and opioid misuse.\n\nCredit education information: The Greater Kansas City Chapter of the American Society for Pain Management Nursing® is approved as a provider of continuing nursing education by the Kansas State Board of Nursing. This course offering has been submitted for approval for nursing contact hours applicable for RN\, LPN and LMHT relicensure.
URL:https://www.ctnnortheastnode.org/event/mindfulness-oriented-recovery-enhancement-clinical-outcomes-and-biobehavioral-mechanisms-of-an-evidence-based-therapy-for-chronic-pain-opioid-misuse-and-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230407T120000
DTEND;TZID=America/New_York:20230407T130000
DTSTAMP:20260403T163750
CREATED:20230317T202141Z
LAST-MODIFIED:20230317T202141Z
UID:3211-1680868800-1680872400@www.ctnnortheastnode.org
SUMMARY:Initiating Buprenorphine for Patients Using Fentanyl
DESCRIPTION:Register Now \nPresenter: Brian Hurley\, MD\, MBA\, DFASAM\, FAPA \nCost: No Fee \nTarget audience: Nurses\, Addictions Specialists\, SUD Project Directors\, Managers\, and Facilitators and MOUD (medications for opioid use disorder) providers \nCredit Designations Available: Nursing CE \nWebinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The presenters will review the evidence for and describe low dose buprenorphine initiation of protocols\, high dose buprenorphine initiation of protocols\, approaches to help support patients stop using full agonist opioids for a longer period of time\, and a clinical approach to referring patients to alternative medications for opioid use disorder. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nCompare and contrast low-dose\, high-dose\, standard dose\, and variations for the timing and setting for initiating buprenorphine to treat opioid use disorder involving fentanyl.\nDesign a treatment plan that factors in the risks and benefits of buprenorphine to treat opioid use disorder in consideration of the set\, setting\, and patient’s priorities for their opioid use disorder treatment.\nRecognize the limitations of buprenorphine treatment of opioid use disorder and how to refer to alternative treatments.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/initiating-buprenorphine-for-patients-using-fentanyl/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230411T150000
DTEND;TZID=America/New_York:20230411T160000
DTSTAMP:20260403T163750
CREATED:20230329T185843Z
LAST-MODIFIED:20230329T185843Z
UID:3214-1681225200-1681228800@www.ctnnortheastnode.org
SUMMARY:Xylazine and How it Harms People Who Use Drugs
DESCRIPTION:Register now! \nPresenters: Raagini Jawa\, MD \nCost: No fee \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nDescription: We will review what is known to date on Xylazine\, a CNS depressant\, which has been linked to an increasing number of overdose deaths in the US. This Roundtable will discuss its physiologic effects\, and risk of xylazine harms including overdose and wounds along with suggested clinical best practices for providers and patients. \nThis talk discusses substance use disorder treatment in a post-COVID world. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/xylazine-and-how-it-harms-people-who-use-drugs/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230419T150000
DTEND;TZID=America/New_York:20230419T160000
DTSTAMP:20260403T163750
CREATED:20230412T162432Z
LAST-MODIFIED:20230412T162432Z
UID:3219-1681916400-1681920000@www.ctnnortheastnode.org
SUMMARY:Opioid Use Disorder and Social Determinants of Health
DESCRIPTION:Presenters: \n  \n\nRachel Talley\, MD\, Assistant Professor of Clinical Psychiatry/Director\, Fellowship in Public and Community Psychiatry\n\n\nJessica Isom\, MD\, Attending Psychiatrist\, Codman Square Health Center/Clinical Instructor\, Yale University/Faculty Lead\, Social Justice and Health Equity Curriculum\n\nSponsor: National Council for Mental Wellbeing–NCMW \nContinuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. \nTarget Audience: Interprofessional teams\, family/patients\, nurses\, physicians\, psychiatrists\, psychologists\, social workers\, students/educators \nAbout the webinar: The opioid crisis continues to have a devastating impact on families and communities across the United States. Individuals from marginalized communities\, including Black\, Indigenous and People of Color (BIPOC) communities and individuals who are uninsured or have lower incomes with opioid use disorders (OUD) often experience challenges accessing and sustaining treatment services. Many of these challenges stem from unaddressed social determinants of health factors (housing\, education\, geography etc.) as well as systemic inequities across all care settings. Lack of attention to these factors can lead to inadequate care for OUD and inadequate support for long-term recovery.we will discuss factors that facilitate and hinder engagement in long-term OUD treatment and recovery for BIPOC individuals\, as well as identify strategies for organizations to assess and effectively address opioid use among BIPOC individuals through addressing social determinants of health. \nEducational objectives: \n\nExamine how social determinants of health may impact initiation of and ongoing substance use\nDiscuss factors that facilitate and hinder engagement in long-term treatment and recovery for BIPOC individuals\nIdentify strategies for organizations to assess and address opioid use among BIPOC individuals through addressing social determinants of health\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/opioid-use-disorder-and-social-determinants-of-health/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230517T120000
DTEND;TZID=America/New_York:20230517T130000
DTSTAMP:20260403T163750
CREATED:20230504T205606Z
LAST-MODIFIED:20230504T205606Z
UID:3223-1684324800-1684328400@www.ctnnortheastnode.org
SUMMARY:Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders
DESCRIPTION:Join us on Wednesday\, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter\, PhD\, MPH\, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will present “Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders.” \nDr. Richter received her Master of Public Health from the University of Kansas Medical School and her PhD in Behavioral Psychology from the University of Kansas Department of Human Development and Family Life\, now known as the Department of Applied Behavioral Sciences. She directs a hospital-based smoking cessation service\, UKanQuit\, that serves over 2\,000 smokers per year. Her professional service includes being a member of editorial boards and serving on a number of NIH and other grant review panels. \n\n\n\nRemote Registration
URL:https://www.ctnnortheastnode.org/event/changing-the-default-moving-to-an-opt-out-approach-for-treating-tobacco-use-disorders/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230522T170000
DTEND;TZID=America/New_York:20230522T190000
DTSTAMP:20260403T163750
CREATED:20230515T190957Z
LAST-MODIFIED:20230515T190957Z
UID:3232-1684774800-1684782000@www.ctnnortheastnode.org
SUMMARY:Drug Use in Pregnancy (ASAM FAME Session 7)
DESCRIPTION:Register Now \nQuestions about registering should be directed to: ASAM Education by email ateducation@asam.org \nPresenters: \n\nAbby Letcher\, MD\, FASAM\nAngela Colistra\, PhD\, LPC\, CAADC\, CCS\nShanna Diaz\, DO\nLeslie Hayes\, MD\n\nSeries: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for on-demand viewing. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: The target audience for this introductory level activity includes: physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. \n  \nRegister Now
URL:https://www.ctnnortheastnode.org/event/drug-use-in-pregnancy-asam-fame-session-7/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230531T120000
DTEND;TZID=America/New_York:20230531T130000
DTSTAMP:20260403T163750
CREATED:20230517T200443Z
LAST-MODIFIED:20230517T200443Z
UID:3233-1685534400-1685538000@www.ctnnortheastnode.org
SUMMARY:Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers
DESCRIPTION:This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment\, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment\, including regulations\, education\, and broader social factors such as stigma. Specific considerations for advanced practice clinicians’ work with members of rural communities will be discussed. Register and attend to learn more! \nSpeakers:\nJoanne Spetz\, PhD\, Director and Brenda and Jeffrey L. Kang Presidential Chair in Health Care Financing at the Philip R. Lee Institute for Health Policy Studies (IHPS)\, University of California San Francisco \nJackie Bray\, DNP; FNP-C\, Family Nurse Practitioner and buprenorphine prescriber\, Howard Center in Vermont \n  \nRegister Now \n  \n  \n 
URL:https://www.ctnnortheastnode.org/event/nurse-practitioners-and-physician-assistants-as-buprenorphine-providers-facilitators-and-barriers/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
END:VCALENDAR